Dr Wen Shi Lee
Research Fellow
Department of Microbiology and Immunology
69 Scholarly works
5 Projects
HIGHLIGHTS
2026
Journal article
Delivery of monoclonal antibodies using mRNA lipid nanoparticles confers protection against SARS-CoV-2 and influenza
DOI: 10.1016/j.omtn.2026.1028732026
Journal article
Evaluating southern pigtail macaques as an immunological model for human antibody responses.
DOI: 10.1038/s41598-026-42695-62026
Journal article
Elevated SARS-CoV-2 IgG4 in plasma and mucosa following repeated mRNA boosters impact antibody functions to Omicron and sarbecoviruses
DOI: 10.1016/j.ebiom.2025.1060872024
Research grants (ARC, NHMRC, MRFF)
Harnessing Antiviral Antibodies for Pandemic Preparedness
2023
Research grants (other domestic)
Monoclonal Antibodies to Treat and Prevent Orthopoxvirus and Henipavirus Pandemic Threats
2021
Journal article
Plasma ACE2 activity is persistently elevated following SARS-CoV-2 infection: Implications for COVID-19 pathogenesis and consequences
DOI: 10.1183/13993003.03730-20202020
Research Grant
“Immunity Passport” to COVID19
RECENT SCHOLARLY WORKS
2025
Journal article
Potent neutralising monoclonal antibodies targeting the spike of NL63 coronavirus
DOI: 10.1038/s44298-025-00116-x2025
Journal article
A novel chimeric coronavirus spike vaccine combining SARS-CoV-2 RBD and scaffold domains from HKU-1 elicits potent neutralising antibody responses
DOI: 10.1038/s41541-025-01323-62025
Journal article
Chimeric coronavirus spike combining SARS-CoV-2 RBD and scaffold domains from HKU-1 elicits potent T helper cell and neutralising antibody responses in murine and non-human primate models 4642
DOI: 10.1093/jimmun/vkaf283.22952025
Journal article
Modulation of germinal center and antibody dynamics via ipsilateral versus contralateral immunization against SARS-CoV-2
DOI: 10.1093/jimmun/vkae0672025
Journal article
Randomized trial of same- versus opposite-arm coadministration of inactivated influenza and SARS-CoV-2 mRNA vaccines
DOI: 10.1172/jci.insight.1870752025
Journal article
Mucosal vaccination against SARS-CoV-2 using recombinant influenza viruses delivering self-assembling nanoparticles
DOI: 10.1016/j.vaccine.2024.1266682025
Journal article
Increased SARS-CoV-2 IgG4 has variable consequences dependent upon Fc function, Fc receptor polymorphism, and viral variant
DOI: 10.1126/sciadv.ads1482
RECENT PROJECTS
2022
Internal Research Grant
Future-Proofing Human Populations Against COVID-19